MARIANA RACOVITA: Open Payments
NPI 1881066272 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,247 in 84 payments from 21 companies in 2025. Trend: 2023 $86 · 2024 $573 · 2025 $2,247
Food & beverage: $2,247
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $707 |
| Otsuka America Pharmaceutical, Inc. | 13 | $336 |
| AstraZeneca Pharmaceuticals LP | 9 | $243 |
| ABBVIE INC. | 11 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $183 |
| Exact Sciences Corporation | 2 | $57 |
| PFIZER INC. | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| ViiV Healthcare Company | 2 | $49 |
Products named: Wegovy, REXULTI, Ozempic, JARDIANCE, AIRSUPRA, QULIPTA, Cologuard Collection Kit, SYNTHROID.
Industry payments across TX — which companies pay providers there.
